UK Clinical Negligence Market Report Published
02 Apr 2019
The UK Clinical Negligence Law Market Trends Report is the second edition of an annual Legal Market Report from IRN Research and provides an overview of the UK clinical negligence law market.
The clinical negligence market is estimated to generate over £650 million in gross revenue for law firms in the UK, with gross revenues having risen over the three years up to 2016/17. However, in the latest year, revenue has slipped. Despite efforts to cut the costs of clinical negligence claims, IRN Research still expects that the market will grow in the next year although growth is likely to slow from 2020/21 onwards as changes to the market are introduced, for example fixed recoverable costs for some claims, more mediation, and the rapid resolution and redress scheme for birth injuries.
Factors likely to have a positive impact on the market are an aging population and rising population resulting in more patient treatment events, so that even with stable medical standards, more actual and potential claims are being generated.
There were less than 17,500 CN cases in 2017/18, decreasing from over 18,000 in the previous year. The ending of legal aid for most clinical negligence cases and the changes to no win, no fee arrangements introduced in 2013/14 have helped cut the number of new cases reported but this still leaves a large number of cases to be closed each year.
However, damages awarded increased in legal CN cases reached £2,227.5 million in 2017/18 increasing from £1,707.2 million in 2016/17. However, £404 million of this increase was due to changes in the personal injury discount rate (PIDR) from 2.5% to -0.75%. The PIDR will be reviewed this year and then every three years.
The report (39pp, PDF), is available directly from IRN Research, priced at £200. UK sterling price is plus VAT so total price is £240. Table of Contents on next page.
Further details, contents page, and order details at www.irn-research.com/reports.